<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02361814</url>
  </required_header>
  <id_info>
    <org_study_id>R15002</org_study_id>
    <nct_id>NCT02361814</nct_id>
  </id_info>
  <brief_title>The Effect of Human Amniotic Membrane Allograft on Functional Recovery After Flexor Tendon Repair</brief_title>
  <official_title>The Effect of Human Amniotic Membrane Allograft on Functional Recovery After Flexor Tendon Repair: a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tampere University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tampere University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Central Finland Hospital District</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tampere University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this pilot study is to gain observational insight into potential preventive&#xD;
      features of amniotic membrane transplantation in the adhesion formation after flexor tendon&#xD;
      repair.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The treatment of flexor tendon transection consists of surgical apposition of the lacerated&#xD;
      tendon ends using non-absorbable sutures. Main complications which result in poor outcome of&#xD;
      the tendon repair are the rupture of the tendon apposition or substantial adhesion formation&#xD;
      between the two tendons or the tendon and the fibro-osseous canal. Adhesion formation is&#xD;
      presumed to be a byproduct of the tendon healing. In the course of last 70 decades, the&#xD;
      preventive effects of several pharmacological agents and mechanical barriers on adhesion&#xD;
      formation have been investigated with some promising findings. One of the mechanical barriers&#xD;
      that has been proposed to be suitable for adhesion prevention is human amniotic membrane&#xD;
      allograft. However, there are no clinical studies evaluating the use of amniotic membrane in&#xD;
      flexor tendon repair.&#xD;
&#xD;
      This is a pilot study for the forthcoming randomized controlled study. The objectives of the&#xD;
      pilot study are: 1) to test the handleability of the human amniotic membrane allograft in&#xD;
      flexor tendon sheath reconstruction in conjunction with flexor tendon repair, 2) to elucidate&#xD;
      the possible adverse effects related to the use of amniotic membrane in flexor the sheath,&#xD;
      and 3) to gain observational insight into potential preventive features of amniotic membrane&#xD;
      transplantation in the adhesion formation. The hypothesis of the pilot study is that the&#xD;
      application of the human amniotic membrane allograft in tendon sheath reconstruction in&#xD;
      flexor tendon injury patients is technically feasible and results in no adverse effects to&#xD;
      the patient.&#xD;
&#xD;
      A total of 10 patients with an acute flexor tendon injury will be included in the pilot&#xD;
      study. After conventional tendoraphia, the amniotic membrane will be wrapped around the&#xD;
      tendons and its borders will be fixed to the remaining tendon sheath. The primary outcome&#xD;
      measure is total range of movement after 6 months of the surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Unfavorable results&#xD;
  </why_stopped>
  <start_date>March 2015</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">September 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total range of movement of the injured finger</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total range of movement of the injured finger</measure>
    <time_frame>2, 4, and 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rupture of the repair</measure>
    <time_frame>2, 4, 8 weeks, and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative infection</measure>
    <time_frame>2, 4, 8 weeks, and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>QuickDASH -score</measure>
    <time_frame>2, 4, 8 weeks, and 6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">5</enrollment>
  <condition>Flexor Tendon Injury</condition>
  <arm_group>
    <arm_group_label>Amniotic membrane allograft group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>After the conventional flexor tendon repair, the amniotic membrane will be wrapped around the tendons and its borders will be fixed to the remaining tendon sheath.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>The use of amnionic membrane allograft</intervention_name>
    <description>After the conventional flexor tendon repair, the amniotic membrane will be wrapped around the tendons and its borders will be fixed to the remaining tendon sheath.</description>
    <arm_group_label>Amniotic membrane allograft group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Acute flexor tendon transection in zone 2 in digits 2, 3, 4, or 5 (diagnosed within 1&#xD;
             week after the injury)&#xD;
&#xD;
          -  Age over 18&#xD;
&#xD;
          -  Patient's willingness to participate in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Tendon transection within 8 mm of its distal insertion (requiring reinsertion)&#xD;
&#xD;
          -  Soft-tissue loss, severe crush, fracture, palmar plate injury, patient requiring&#xD;
             revascularization&#xD;
&#xD;
          -  Cognitive impairment or other factors (prisoner, military serviceman) which may affect&#xD;
             one's decision making&#xD;
&#xD;
          -  Substance abuse&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Harry Göransson, M.D., Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Tampere University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Tampere</name>
      <address>
        <city>Tampere</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <study_first_submitted>February 3, 2015</study_first_submitted>
  <study_first_submitted_qc>February 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 12, 2015</study_first_posted>
  <last_update_submitted>June 25, 2017</last_update_submitted>
  <last_update_submitted_qc>June 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tampere University</investigator_affiliation>
    <investigator_full_name>Olli Leppänen</investigator_full_name>
    <investigator_title>Researcher</investigator_title>
  </responsible_party>
  <keyword>flexor tendon</keyword>
  <keyword>finger</keyword>
  <keyword>amniotic membrane</keyword>
  <keyword>allograft</keyword>
  <keyword>tendon injury</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tendon Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

